Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
Phase 1
Active, not recruiting
- Conditions
- Varicella Zoster Virus InfectionHerpes Zoster
- Interventions
- First Posted Date
- 2024-05-10
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT06409494
- Locations
- ๐ฐ๐ท
The Catholic University of Eunpyeong St.Mary's Hospital, Seoul, Korea, Republic of
Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years
Phase 1
Active, not recruiting
- Conditions
- Respiratory Syncytial Virus (RSV)Respiratory Syncytial Virus Infections
- Interventions
- Other: Placebo Comparator
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06216093
- Locations
- ๐ฐ๐ท
Univsersity Hospital, Seoul, Korea, Republic of
Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
Phase 1
Completed
- Conditions
- Infection, Meningococcal
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT05739292
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 2852
- Registration Number
- NCT05603052
- Locations
- ๐จ๐ฉ
Trial site, Kinshasa, Congo, The Democratic Republic of the
A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
Phase 3
Completed
- Conditions
- COVID-19
- First Posted Date
- 2022-10-10
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 2600
- Registration Number
- NCT05572879
- Locations
- ๐ต๐ญ
Trial site, Manila, Philippines
Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
Phase 3
Completed
- Conditions
- Glabellar Frown Lines
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 290
- Registration Number
- NCT04830345
- Locations
- ๐ฐ๐ท
Nowon Eulji University Hospital, Seoul, Korea, Republic of
Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults
Phase 1
Completed
- Conditions
- Pneumococcal Disease
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT04830358
- Locations
- ๐ฐ๐ท
The Catholic University of Seoul St.Mary's Hospital, Seoul, Korea, Republic of
Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
Phase 2
Completed
- Conditions
- Typhoid Fever
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 444
- Registration Number
- NCT04830371
- Locations
- ๐ต๐ญ
De La Salle Medical and Health Sciences Institute, Cavite, Philippines
๐ต๐ญUniversity of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines
Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults
Phase 1
Completed
- Conditions
- COVID-19
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 279
- Registration Number
- NCT04783311
- Locations
- ๐ฐ๐ท
The Catholic University of Eunpyeong St.Mary's Hospital, Seoul, Korea, Republic of
Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old
Phase 1
Completed
- Conditions
- Infection, Meningococcal
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- EuBiologics Co.,Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT04714229
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of